{"article_title": "Medtronic\u2019s $43 billion Covidien deal may signal more to come", "article_keywords": ["billion", "johnson", "deal", "come", "signal", "tax", "43", "cash", "driven", "covidien", "outside", "medtronics", "medical", "medtronic"], "article_url": "http://www.cnbc.com/2014/06/16/medtronics-43-billion-covidien-deal-may-signal-more-to-come.html", "article_text": "Medtronic's deal to buy Covidien for $42.9 billion may just be the first domino in a lineup that consolidates the medical-device industry.\n\nThe acquisition, announced Sunday night, brings together the No. 4 and No. 8 players in medical devices to create the second-largest company in the industry, after Johnson & Johnson, according to Wells Fargo analyst Larry Biegelsen. While Medtronic will reincorporate in Covidien's home country, Ireland, in yet another inversion to take advantage of lower taxes outside the U.S., this deal is driven by more than tax considerations.\n\nRead MoreMedtronic's $43B Covidien deal\u2014and Irish tax move\n\n\"We believe that the Covidien deal is being driven by the need for Medtronic to have access to its OUS [outside the U.S.] cash, management's interest in becoming more relevant to hospitals by gaining scale across multiple segments of medical technology, and cost savings,\" Biegelsen wrote in a Monday research note. Medtronic has about $14 billion in cash, most of it outside the U.S.\n\n", "article_metadata": {"AssetType": "cnbcnewsstory", "description": "Medtronic's $43 billion Covidien deal, which boosts its negotiating power for the Affordable Care Act, may be a sign of future medical-device mergers.", "news_keywords": "Medtronic Covidien merger, medical-device mergers, Affordable Care Act", "author": "Meg Tirrell", "og": {"site_name": "CNBC", "description": "Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.", "title": "Medtronic\u2019s $43B Covidien deal: More to come?", "url": "http://www.cnbc.com/2014/06/16/medtronics-43-billion-covidien-deal-may-signal-more-to-come.html", "image": "http://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2014/06/16/101762337-RTXZE5K.1910x1000.jpg", "type": "article"}, "twitter": {"description": "Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.", "creator": "@megtirrell", "url": "http://www.cnbc.com/2014/06/16/medtronics-43-billion-covidien-deal-may-signal-more-to-come.html", "image": {"src": "http://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2014/06/16/101762337-RTXZE5K.1910x1000.jpg"}, "title": "Medtronic\u2019s $43 billion Covidien deal may signal more to come", "site": "@CNBC", "card": "summary_large_image"}, "al": {"ios": {"app_name": "CNBC Business News and Finance", "app_store_id": 398018310}}, "apple-itunes-app": "app-id=398018310", "keywords": "Mergers and Acquisitions, Biotech and Pharmaceuticals, Pharmaceuticals, Health Care IT, Health Care, Mergers and Acquisitions, Medtronic PLC, Covidien Public Limited Company, Johnson & Johnson, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Co, Stryker Corp, Smith & Nephew PLC, Abbott Laboratories, Zimmer Biomet Holdings Inc, Becton, Dickinson and Co, St. Jude Medical Inc, business news", "article": {"publisher": "https://www.facebook.com/cnbc", "published_time": "2014-06-16T09:26:49-0400", "author": "https://www.facebook.com/CNBC", "section": "Mergers and Acquisitions", "modified_time": "2014-06-16T09:37:11-0400", "tag": "St. Jude Medical Inc"}, "pageNodeId": 101761867, "GOOGLEBOT": "unavailable_after: 31 Dec 9999 23:59:59 GMT"}, "_id": "\"57477af46914bd0286fe1216\"", "article_summary": "Medtronic's deal to buy Covidien for $42.9 billion may just be the first domino in a lineup that consolidates the medical-device industry.\n8 players in medical devices to create the second-largest company in the industry, after Johnson & Johnson, according to Wells Fargo analyst Larry Biegelsen.\nMedtronic has about $14 billion in cash, most of it outside the U.S.\nWhile Medtronic will reincorporate in Covidien's home country, Ireland, in yet another inversion to take advantage of lower taxes outside the U.S., this deal is driven by more than tax considerations.\nThe acquisition, announced Sunday night, brings together the No."}